ABSTRACT
Lack of knowledge is the main problem we face in the global Covid-19 pandemic. SARS-CoV-2 is a new virus of which there were no previous studies.
Using data from 50 very different countries and by means of a regression analysis, we studied the degree to which a series of variables (health indicators, environmental parameters, economic and social indicators, general characteristics of the country) were able to predict the number of people infected and killed by Covid-19. We also studied how these variables were changing their ability to predict the number of infected and dead by covid-19 during a 3 months period (March, April, May).
The number of deaths by Covid-19 can always be predicted with great accuracy from the number of infected, regardless of the characteristics of the country (which has better or worse health, greater or lesser wealth, regardless of its population structure…). Epidemiological measures to prevent transmission, mainly travel and mobility restrictions, proved to be much more efficient than having large hospital and medical resources.
Inbound tourism turned out to be the variable that best predicts the number of infected (and, consequently, the number of deaths) happening in the different countries. Electricity consumption and degree of air pollution of a country (CO2 emissions, nitrous oxide and methane) are also capable of predicting, with great precision, the number of infections and deaths from Covid-19 in that country. Characteristics such as the area and population of a country also can predict, although to a lesser extent, the number of infected and dead.
In contrast, a series of variables, which in principle would seem to have a greater influence on the evolution of Covid-19 (hospital bed density, Physicians per 1000 people, Researches in R & D, urban population…), turned out to have very little ability to predict both the number of infected and the number of deaths from Covid-19.
All this may explain why the countries that opted for social withdrawal policies since the start of the pandemic outbreak obtained better results.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was required to develop this paper
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Complutense University Madrid
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos